Acute Cerebral Infarction Following Intravenous Glycoprotein IIb/IIIa Inhibitor for Acute Myocardial Infarction.
10.4070/kcj.2011.41.9.546
- Author:
Woong Gil CHOI
1
;
Se Won OH
;
Young Joong KIM
;
Jong Gu LIM
;
Yoon Sik JO
Author Information
1. Department of Cardiology, Konkuk University School of Medicine, Chungju Hospital, Chungju, Korea. gilll@paran.com
- Publication Type:Case Report
- Keywords:
Myocardial infarction;
Acute stroke;
Platelet glycoprotein GP IIb-IIIa complex
- MeSH:
Acute Coronary Syndrome;
Cerebral Infarction;
Glycoproteins;
Humans;
Incidence;
Middle Aged;
Myocardial Infarction;
Percutaneous Coronary Intervention;
Stroke
- From:Korean Circulation Journal
2011;41(9):546-548
- CountryRepublic of Korea
- Language:English
-
Abstract:
Stroke is a rare but serious complication of acute myocardial infarction (AMI). Currently, glycoprotein (GP) IIb/IIIa inhibitor is used in clinical practice for acute coronary syndromes and percutaneous coronary interventions (PCIs). The incidence of stroke in patients receiving GP IIb/IIIa inhibitor during PCIs is very low. We report the case of a 47-year-old man who presented with AMI and suffered an acute cerebral infarction after infusion of a GP IIb/IIIa inhibitor following primary PCI.
